JP2006328073A5 - - Google Patents

Download PDF

Info

Publication number
JP2006328073A5
JP2006328073A5 JP2006157094A JP2006157094A JP2006328073A5 JP 2006328073 A5 JP2006328073 A5 JP 2006328073A5 JP 2006157094 A JP2006157094 A JP 2006157094A JP 2006157094 A JP2006157094 A JP 2006157094A JP 2006328073 A5 JP2006328073 A5 JP 2006328073A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
het
halo
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006157094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006328073A (ja
JP4815566B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2006328073A publication Critical patent/JP2006328073A/ja
Publication of JP2006328073A5 publication Critical patent/JP2006328073A5/ja
Application granted granted Critical
Publication of JP4815566B2 publication Critical patent/JP4815566B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006157094A 1999-04-30 2006-06-06 グルココルチコイド受容体モジュレーター Expired - Fee Related JP4815566B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13213099P 1999-04-30 1999-04-30
US60/132,130 1999-04-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000615356A Division JP3901945B2 (ja) 1999-04-30 2000-03-27 グルココルチコイド受容体モジュレーター

Publications (3)

Publication Number Publication Date
JP2006328073A JP2006328073A (ja) 2006-12-07
JP2006328073A5 true JP2006328073A5 (OSRAM) 2007-05-10
JP4815566B2 JP4815566B2 (ja) 2011-11-16

Family

ID=22452621

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000615356A Expired - Fee Related JP3901945B2 (ja) 1999-04-30 2000-03-27 グルココルチコイド受容体モジュレーター
JP2006157094A Expired - Fee Related JP4815566B2 (ja) 1999-04-30 2006-06-06 グルココルチコイド受容体モジュレーター

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000615356A Expired - Fee Related JP3901945B2 (ja) 1999-04-30 2000-03-27 グルココルチコイド受容体モジュレーター

Country Status (45)

Country Link
US (3) US6380223B1 (OSRAM)
EP (1) EP1175383B1 (OSRAM)
JP (2) JP3901945B2 (OSRAM)
KR (1) KR100511585B1 (OSRAM)
CN (2) CN1275917C (OSRAM)
AP (1) AP1542A (OSRAM)
AR (1) AR032128A1 (OSRAM)
AU (1) AU776608B2 (OSRAM)
BG (3) BG110227A (OSRAM)
BR (1) BR0010138B1 (OSRAM)
CA (2) CA2372173A1 (OSRAM)
CO (1) CO5280071A1 (OSRAM)
CR (2) CR6478A (OSRAM)
CU (1) CU23111A3 (OSRAM)
CZ (1) CZ304203B6 (OSRAM)
DZ (1) DZ3038A1 (OSRAM)
EA (2) EA007483B1 (OSRAM)
EE (1) EE05584B1 (OSRAM)
EG (1) EG25606A (OSRAM)
GE (1) GEP20053474B (OSRAM)
GT (1) GT200000053A (OSRAM)
HK (1) HK1042889B (OSRAM)
HR (1) HRP20010804B1 (OSRAM)
HU (1) HUP0201243A3 (OSRAM)
IL (3) IL145450A0 (OSRAM)
IS (1) IS2743B (OSRAM)
MA (1) MA26729A1 (OSRAM)
MX (1) MXPA01011018A (OSRAM)
MY (1) MY133378A (OSRAM)
NO (1) NO327612B1 (OSRAM)
NZ (1) NZ514465A (OSRAM)
OA (1) OA11877A (OSRAM)
PA (1) PA8493801A1 (OSRAM)
PE (1) PE20010112A1 (OSRAM)
PL (1) PL207610B1 (OSRAM)
RS (1) RS52134B (OSRAM)
SK (1) SK287535B6 (OSRAM)
SV (1) SV2004000061A (OSRAM)
TN (1) TNSN00093A1 (OSRAM)
TR (1) TR200103104T2 (OSRAM)
TW (2) TWI309566B (OSRAM)
UA (1) UA74145C2 (OSRAM)
UY (1) UY26129A1 (OSRAM)
WO (1) WO2000066522A1 (OSRAM)
ZA (1) ZA200108846B (OSRAM)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201243A3 (en) * 1999-04-30 2002-11-28 Pfizer Prod Inc Glucocorticoid receptor modulators, pharmaceutical compositions containing them and their use
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
SI1305329T2 (sl) 2000-08-05 2015-07-31 Glaxo Group Limited S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-(2-furanilkarboksil)oksi-11beta-hidroksi- 16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
IL146057A (en) * 2000-10-27 2007-09-20 Pfizer Prod Inc A process for the preparation of modulators of a non-steroidal glucocorticoid receptor
ES2262612T3 (es) * 2000-10-28 2006-12-01 Pfizer Products Inc. Moduladpres del receptor de glucocorticoides.
DE60113032T2 (de) 2000-10-30 2006-07-06 Pfizer Products Inc., Groton Glukokortikoidrezeptor-Modulatoren
CA2445839A1 (en) 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
US8193172B2 (en) 2001-11-23 2012-06-05 Pop Test Cortisol Llc Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists
US20060148725A1 (en) * 2001-12-21 2006-07-06 The Miriam Hospital Selective 11beta HSD inhibitors and methods of use thereof
AU2002361861A1 (en) * 2001-12-21 2003-07-30 Rhode Island Hospital SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF
CA2472746A1 (en) 2002-01-14 2003-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
DE60318188T2 (de) 2002-03-26 2008-12-11 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
JP2005521717A (ja) 2002-03-26 2005-07-21 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
EP1521733B1 (en) * 2002-07-08 2014-08-20 Pfizer Products Inc. Modulators of the glucocorticoid receptor
WO2004018429A2 (en) 2002-08-21 2004-03-04 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
KR20050036982A (ko) * 2002-08-29 2005-04-20 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 염증, 알러지 및 증식성 질환의 치료에 글루코코르티코이드모사체로 사용하기 위한 3-(설폰아미도에틸)-인돌 유도체
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
AU2003267728A1 (en) * 2002-10-18 2004-05-04 Pfizer Products Inc. Cannabinoid receptor ligands and uses thereof
CA2504751C (en) * 2002-11-05 2013-02-05 Corcept Therapeutics, Inc. Methods for treating gastroesophageal reflux disease
US20060052354A1 (en) * 2002-11-05 2006-03-09 Corcept Therapeutics, Inc. Methods for treating migraine
EP1583745A1 (en) 2003-01-03 2005-10-12 Boehringer Ingelheim Pharmaceuticals Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
TW200503994A (en) * 2003-01-24 2005-02-01 Novartis Ag Organic compounds
WO2004097002A2 (en) * 2003-04-29 2004-11-11 The Miriam Hospital SELECTIVE TESTICULAR 11β-HSD INHIBITORS AND METHODS OF USE THEREOF
NZ527142A (en) * 2003-07-23 2006-03-31 Douglas Pharmaceuticals Ltd A stable suspension formulation
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
EP1675839B1 (en) 2003-10-16 2007-07-11 Boehringer Ingelheim Pharmaceuticals Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
WO2005047254A1 (en) * 2003-11-13 2005-05-26 Pfizer Products Inc. Octahydrophenanthrene hydrazinde derivatives useful as glucocorticoid receptor modulators
EP1689390B1 (en) 2003-11-21 2011-02-09 Zalicus Inc. Methods and reagents for the treatment of inflammatory disorders
US7253283B2 (en) * 2004-01-16 2007-08-07 Bristol-Myers Squibb Company Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7795272B2 (en) * 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
US20050261292A1 (en) * 2004-05-19 2005-11-24 Solvay Pharmaceuticals Gmbh Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions
US20090156565A1 (en) * 2004-12-03 2009-06-18 The Children's Hospital Of Philadelphia Composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug
ES2326907T3 (es) 2004-12-27 2009-10-21 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para su preparacion, composiciones farmaceuticas y su uso.
TWI435729B (zh) 2005-11-09 2014-05-01 Combinatorx Inc 治療病症之方法，組合物及套組
US7640389B2 (en) * 2006-02-28 2009-12-29 Freescale Semiconductor, Inc. Non-volatile memory having a multiple block erase mode and method therefor
US20080045475A1 (en) * 2006-08-20 2008-02-21 Phillip Edward Littmann Elemental cellular therapy is a genetic, cellular and disease-modifying therapy which enhances the systemic conduct of genetic and cellular transmethylation activity resulting in enhancement of concerted genetic and cellular metabolic, physiologic and homeostatic processes
BRPI0720131A2 (pt) * 2006-12-06 2014-02-04 Boehringer Ingelheim Int Glicocorticoides miméticos, métodos para fazê-los, composições farmacêuticas e usos dos mesmos.
AP2411A (en) * 2007-02-02 2012-05-30 Pfizer Prod Inc Tricyclic compounds and their use as glucocorticoid receptor modulators
CA2676670C (en) * 2007-02-02 2012-03-13 Pfizer Products Inc. Tricyclic compounds, compositions, and methods
KR20110020902A (ko) * 2008-06-06 2011-03-03 베링거 인겔하임 인터내셔날 게엠베하 글루코코르티코이드 유사체, 이의 제조방법, 약제학적 조성물 및 이의 용도
BRPI0917212A2 (pt) 2008-07-28 2015-11-10 Pfizer compostos de fenantrenona, seus usos na preparação de composições, e composições compreendendo os referidos compostos
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
CN101338200B (zh) * 2008-08-20 2011-08-17 石家庄国大工业有限公司 一种tn型液晶材料的混合物
US9216221B2 (en) * 2008-11-07 2015-12-22 University Of Sheffield Medicament and method of diagnosis for treating subclinical Cushing's syndrome
EP2459524A2 (en) 2009-07-31 2012-06-06 Cadila Healthcare Limited Novel compounds as modulators of glucocorticoid receptors
NZ598462A (en) 2009-08-31 2012-12-21 Merck Sharp & Dohme Pyranyl aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
EP2632892B1 (en) * 2010-10-27 2014-07-30 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Diterpenoid derivatives endowed of biological properties
MX2013010576A (es) * 2011-03-15 2014-03-12 Abbvie Inc Moduladores de receptores de hormonas nucleares.
US9573898B2 (en) 2011-09-21 2017-02-21 Givaudan S.A. Pyridine derivates and their use as Umami tastants
TW201422590A (zh) 2012-09-07 2014-06-16 Abbvie Inc 雜環核激素受體調節劑
EP2935284A4 (en) * 2012-12-21 2016-04-27 Abbvie Inc HETEROCYCLIC MODULATORS OF HORMONE NUCLEAR RECEPTORS
SG11201506796XA (en) * 2013-03-14 2015-09-29 Bristol Myers Squibb Co Bicyclo [2.2.1] acid gpr120 modulators
CZ2014575A3 (cs) * 2014-08-26 2016-02-24 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. Amfifilní sloučeniny s neuroprotektivními účinky
SK592017A3 (sk) * 2017-07-04 2019-01-08 Saneca Pharmaceuticals A. S. Spôsob prípravy morfínanových zlúčenín
EP3821220B1 (en) 2018-08-22 2024-11-13 University of Utah Research Foundation Force and torque sensor for prosthetic and orthopedic devices
WO2020047043A1 (en) 2018-08-28 2020-03-05 Lenzi Tommaso Variable transmission for assistive prosthesis device
ES2980934T3 (es) 2019-01-22 2024-10-03 Akribes Biomedical Gmbh Modificadores selectivos del receptor de glucocorticoides para tratar la cicatrización alterada de heridas en la piel
US20220288091A1 (en) * 2019-03-18 2022-09-15 Lynnette K. NIEMAN Method for Improving Insulin Sensitivity
JP7716113B2 (ja) 2020-03-20 2025-07-31 ユニバーシティ オブ ユタ リサーチ ファウンデーション 受動型および動力付き外骨格における自己整列機構

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4514056Y1 (OSRAM) 1965-09-09 1970-06-15
US3516993A (en) * 1967-03-15 1970-06-23 Sandoz Ag Benzylidene-substituted nitrogenous heterocyclic compounds
US3683091A (en) 1967-11-13 1972-08-08 Wataru Nagata Certain phenanthrene compounds for treatment of acne
JPS50111098A (OSRAM) * 1974-02-18 1975-09-01
JPS6183138A (ja) 1984-09-28 1986-04-26 Harima Kasei Kogyo Kk ３−デオキシアフィディコリンの製造方法
FR2576025B1 (fr) * 1985-01-14 1987-01-23 Roussel Uclaf Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
JPS61271216A (ja) 1985-05-27 1986-12-01 Mitsubishi Chem Ind Ltd 抗腫瘍剤
JPS6256422A (ja) 1985-09-04 1987-03-12 Mitsubishi Chem Ind Ltd 抗菌剤
JPH07100357B2 (ja) 1986-03-11 1995-11-01 三菱化学株式会社 繊維補強セメントモルタル成形体
US5039706A (en) 1987-11-30 1991-08-13 Du Pont Merck Pharmaceutical Company Antiinflammatory PLA2 inhibitors
US5116865A (en) * 1990-09-05 1992-05-26 Peters Richard H 15,16-seco-19-nor progestins
JPH06263688A (ja) 1991-09-04 1994-09-20 Otsuka Pharmaceut Factory Inc フェナンスレン誘導体
EP0676196A1 (en) 1993-10-13 1995-10-11 Otsuka Pharmaceutical Co., Ltd. Nitrogen monoxide synthesis inhibitor
CA2149496C (en) 1994-05-19 2006-12-19 Ronald Gebhard 11,21-bisphenyl-19-norpregnane derivatives
JPH0952899A (ja) 1994-09-30 1997-02-25 Tsumura & Co ロイコトリエン拮抗剤
US5693646A (en) 1994-12-22 1997-12-02 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
US5767113A (en) 1995-05-10 1998-06-16 The Salk Institute For Biological Studies Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance
US5725694A (en) * 1996-11-25 1998-03-10 Reynolds Metals Company Free-machining aluminum alloy and method of use
FR2757400B1 (fr) 1996-12-19 1999-12-17 Hoechst Marion Roussel Inc Application des composes antiglucocorticoides dans le traitement des psychoses ou des comportements addictifs
AU5729098A (en) 1996-12-24 1998-07-17 Zymogenetics Inc. Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes
IL122740A (en) * 1997-01-15 2003-09-17 Akzo Nobel Nv 16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them
EP0903146A1 (en) 1997-09-23 1999-03-24 Applied Research Systems ARS Holdings N.V. 21-Hydroy-6,19-oxidoprogesterone (210h-60p) as antiglucocorticoid
HUP0201243A3 (en) * 1999-04-30 2002-11-28 Pfizer Prod Inc Glucocorticoid receptor modulators, pharmaceutical compositions containing them and their use

Similar Documents

Publication Publication Date Title
JP2006328073A5 (OSRAM)
JP5588040B2 (ja) Ｓ１ｐ１／ｅｄｇ１受容体アゴニストとしてのアミノ−ピリジン誘導体
US8106078B2 (en) Human protein tyrosine phosphatase inhibitors and methods of use
JP2008511683A5 (OSRAM)
JP5837936B2 (ja) アルキルスルフィニル置換チアゾリド化合物
US12145924B2 (en) Lysophosphatidic acid receptor 1 (LPAR1) inhibitor compounds
JP2010504913A5 (OSRAM)
JP2002529532A5 (OSRAM)
JP2009519965A5 (OSRAM)
JP2007535551A5 (OSRAM)
JP2013532726A5 (OSRAM)
JP2009537559A5 (OSRAM)
JP2008513514A5 (OSRAM)
HRP20110335T1 (hr) Supstituirani biciklolaktamski spojevi
JP2007531744A5 (OSRAM)
JP2009533410A5 (OSRAM)
JP2006517939A5 (OSRAM)
JP2013527847A5 (OSRAM)
NZ592297A (en) 2-Aryl-5-heteroaryl pyridine and pyrimidine derivatives as pharmaceutical active agents
JP2010513438A5 (OSRAM)
JP2012524110A5 (OSRAM)
JP2007502817A5 (OSRAM)
JP2011517674A (ja) 嚢胞性線維症膜コンダクタンス制御因子の水溶性小分子阻害剤
JP2005526696A5 (OSRAM)
US20070032501A1 (en) Aryl pyridines and methods of their use